Issues
-
Cover image
Cover Image
Cover: The Venus of Willendorf, a limestone figurine that is ∼11 cm high and dated 22,000-24,000 BC, was found in 1908 by the archaeologist Josef Szombathy near the town of Willendorf in Austria, and is now displayed in the Naturhistorisches Museum in Vienna. It is the most famous of a series of Upper Paleolithic Venus figurines found in middle Europe. Often described as mother goodness or as an amulet of fertility, it has also been heralded as the first example of obesity in human evolutionary history. Although it is unlikely that any human being who endured the fast and famines of the Paleolithic age would have had the chance to become obese, the figurine's enigmatic nature and round shape perfectly represent the mystery of why we are 'The obese species'. Image credit: Matthias Kabel; adapted under the GNU Free Documentation License. - PDF Icon PDF LinkTable of contents
Foreword
In This Issue
Research Highlights
Editorial
Journal Club
Fasting, feasting and the glutamatergic synapse
Summary and comment on a recent Neuron paper entitled ‘Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone’ (Liu et al., 2012).
A Model For Life
Leading the charge in leptin research: an interview with Jeffrey Friedman
Jeffrey Friedman is a molecular geneticist whose group, in 1994, reported the long-sought identity and function of leptin (Zhang et al., 1994), a key fat-derived hormone that regulates feeding behaviour and body weight. This represented a massive step forward in our understanding of obesity, which is now one of the world’s fastest-growing health problems. Here, he recalls his journey of discovery and offers his perspective on the future of obesity research.
Obituary
Zofia Zukowska
The death of Zofia Zukowska, on April 15, 2012, represents the loss of a vibrant and energetic leader in the fields of stress physiology and neuropeptide Y (NPY) biology.
At A Glance
Special Article
Commentaries
Research Articles
Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model
Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats
Research Reports
DMM Journal Meeting 2024: Pre-clinical Modelling of Human Genetic Disease and Therapy

Registration is now open for our 2024 Journal Meeting. Rapid advances in gene editing and genetic technologies have revolutionised our ability to model human genetic disease and provided new hope for gene therapies. At this Meeting, we will present the very latest advances in modelling human genetic disease.
Moving towards heart success – Disease Models & Mechanisms Special Issue

DMM's most recent special issue compiles articles that aim to move heart failure to heart success by fundamentally addressing the roots of failure to identify curative strategies.
Crossroads in Virology

Our October Editorial written by Sumana Sanyal emphasises the urgency of a concerted effort in understanding virus–host interactions to inform the development of therapeutics and vaccines, helping to predict disease outcomes. Read the full Editorial here.
A Model for Life - an interview with Professor Kiran Musunuru




Read our new A Model for Life interview with Kiran Musunuru. Prof Musunuru investigates the mechanisms of disease in model systems, with the ultimate goal of developing innovative gene editing therapies.
Sustainable Conferencing Initiative

Through our Sustainable Conferencing Grants, we promote the use of new technology and greener modes of travel. Our blog posts showcase examples of sustainability in action and share experience about how new technologies and conference formats work in practice.